IBDEI1XV ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30965,1,4,0)
 ;;=4^M31.1
 ;;^UTILITY(U,$J,358.3,30965,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,30966,0)
 ;;=E85.81^^123^1598^7
 ;;^UTILITY(U,$J,358.3,30966,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30966,1,3,0)
 ;;=3^Light Chain (AL) Amyloidosis
 ;;^UTILITY(U,$J,358.3,30966,1,4,0)
 ;;=4^E85.81
 ;;^UTILITY(U,$J,358.3,30966,2)
 ;;=^5151302
 ;;^UTILITY(U,$J,358.3,30967,0)
 ;;=E85.82^^123^1598^23
 ;;^UTILITY(U,$J,358.3,30967,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30967,1,3,0)
 ;;=3^Wild-Type Transthyretin-Related (ATTR) Amyloidosis
 ;;^UTILITY(U,$J,358.3,30967,1,4,0)
 ;;=4^E85.82
 ;;^UTILITY(U,$J,358.3,30967,2)
 ;;=^5151303
 ;;^UTILITY(U,$J,358.3,30968,0)
 ;;=E85.89^^123^1598^1
 ;;^UTILITY(U,$J,358.3,30968,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30968,1,3,0)
 ;;=3^Amyloidosis,Other
 ;;^UTILITY(U,$J,358.3,30968,1,4,0)
 ;;=4^E85.89
 ;;^UTILITY(U,$J,358.3,30968,2)
 ;;=^334034
 ;;^UTILITY(U,$J,358.3,30969,0)
 ;;=Z87.442^^123^1599^1
 ;;^UTILITY(U,$J,358.3,30969,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30969,1,3,0)
 ;;=3^Personal Hx of Urinary Calculi
 ;;^UTILITY(U,$J,358.3,30969,1,4,0)
 ;;=4^Z87.442
 ;;^UTILITY(U,$J,358.3,30969,2)
 ;;=^5063497
 ;;^UTILITY(U,$J,358.3,30970,0)
 ;;=N20.0^^123^1599^2
 ;;^UTILITY(U,$J,358.3,30970,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30970,1,3,0)
 ;;=3^Calculus of Kidney
 ;;^UTILITY(U,$J,358.3,30970,1,4,0)
 ;;=4^N20.0
 ;;^UTILITY(U,$J,358.3,30970,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,30971,0)
 ;;=N20.1^^123^1599^3
 ;;^UTILITY(U,$J,358.3,30971,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30971,1,3,0)
 ;;=3^Calculus of Ureter
 ;;^UTILITY(U,$J,358.3,30971,1,4,0)
 ;;=4^N20.1
 ;;^UTILITY(U,$J,358.3,30971,2)
 ;;=^5015608
 ;;^UTILITY(U,$J,358.3,30972,0)
 ;;=N20.2^^123^1599^4
 ;;^UTILITY(U,$J,358.3,30972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30972,1,3,0)
 ;;=3^Calculus of Kidney w/ Calculus of Ureter
 ;;^UTILITY(U,$J,358.3,30972,1,4,0)
 ;;=4^N20.2
 ;;^UTILITY(U,$J,358.3,30972,2)
 ;;=^5015609
 ;;^UTILITY(U,$J,358.3,30973,0)
 ;;=N20.9^^123^1599^5
 ;;^UTILITY(U,$J,358.3,30973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30973,1,3,0)
 ;;=3^Urinary Calculus,Unspec
 ;;^UTILITY(U,$J,358.3,30973,1,4,0)
 ;;=4^N20.9
 ;;^UTILITY(U,$J,358.3,30973,2)
 ;;=^5015610
 ;;^UTILITY(U,$J,358.3,30974,0)
 ;;=E72.53^^123^1599^6
 ;;^UTILITY(U,$J,358.3,30974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30974,1,3,0)
 ;;=3^Hyperoxaluria
 ;;^UTILITY(U,$J,358.3,30974,1,4,0)
 ;;=4^E72.53
 ;;^UTILITY(U,$J,358.3,30974,2)
 ;;=^60210
 ;;^UTILITY(U,$J,358.3,30975,0)
 ;;=R78.89^^123^1600^1
 ;;^UTILITY(U,$J,358.3,30975,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30975,1,3,0)
 ;;=3^Lithium Toxicity
 ;;^UTILITY(U,$J,358.3,30975,1,4,0)
 ;;=4^R78.89
 ;;^UTILITY(U,$J,358.3,30975,2)
 ;;=^5019588
 ;;^UTILITY(U,$J,358.3,30976,0)
 ;;=Z99.2^^123^1601^3
 ;;^UTILITY(U,$J,358.3,30976,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30976,1,3,0)
 ;;=3^Dependence on Renal Dialysis
 ;;^UTILITY(U,$J,358.3,30976,1,4,0)
 ;;=4^Z99.2
 ;;^UTILITY(U,$J,358.3,30976,2)
 ;;=^5063758
 ;;^UTILITY(U,$J,358.3,30977,0)
 ;;=Z91.15^^123^1601^6
 ;;^UTILITY(U,$J,358.3,30977,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30977,1,3,0)
 ;;=3^Noncompliance w/ Renal Dialysis
 ;;^UTILITY(U,$J,358.3,30977,1,4,0)
 ;;=4^Z91.15
 ;;^UTILITY(U,$J,358.3,30977,2)
 ;;=^5063617
 ;;^UTILITY(U,$J,358.3,30978,0)
 ;;=Z49.31^^123^1601^1
